Rhythm Pharmaceuticals, Inc. (RYTM) stock
RYTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 5/30276% above fair value
$119.04+2.43 (+2.08%)
Close on Nov 18, 2026Market cap $8.20BP/E –Yield –
Rhythm Pharmaceuticals free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Rhythm Pharmaceuticals's free cash flow for the twelve months ending Dec 31, 2023 was -$136.20M. For fiscal 2025 it was -$116.63M. The highest annual figure on record is -$6.99M in fiscal 2015.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$116.63M | – |
| FY2024 | Dec 31, 2024 | -$113.88M | – |
| FY2023 | Dec 31, 2023 | -$136.20M | – |
| FY2022 | Dec 31, 2022 | -$173.71M | – |
| FY2021 | Dec 31, 2021 | -$146.44M | – |
| FY2020 | Dec 31, 2020 | -$122.19M | – |
| FY2019 | Dec 31, 2019 | -$126.14M | – |
| FY2018 | Dec 31, 2018 | -$62.78M | – |
| FY2017 | Dec 31, 2017 | -$29.59M | – |
| FY2016 | Dec 31, 2016 | -$24.28M | – |
| FY2015 | Dec 31, 2015 | -$6.99M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2023 | Dec 31, 2023 | -$29.38M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.25M | – |
| Q2 FY2023 | Jun 30, 2023 | -$41.09M | – |
| Q1 FY2023 | Mar 31, 2023 | -$36.48M | – |
| Q4 FY2022 | Dec 31, 2022 | -$34.00M | – |
| Q3 FY2022 | Sep 30, 2022 | -$47.08M | – |
| Q2 FY2022 | Jun 30, 2022 | -$38.87M | – |
| Q1 FY2022 | Mar 31, 2022 | -$53.76M | – |
| Q4 FY2021 | Dec 31, 2021 | -$40.54M | – |
| Q3 FY2021 | Sep 30, 2021 | -$40.27M | – |
| Q2 FY2021 | Jun 30, 2021 | -$32.09M | – |
| Q1 FY2021 | Mar 31, 2021 | -$33.54M | – |
| Q4 FY2020 | Dec 31, 2020 | -$29.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$32.22M | – |
| Q3 FY2019 | Sep 30, 2019 | -$33.86M | – |
| Q2 FY2019 | Jun 30, 2019 | -$27.86M | – |
| Q1 FY2019 | Mar 31, 2019 | -$32.19M | – |
| Q4 FY2018 | Dec 31, 2018 | -$21.38M | – |
| Q3 FY2018 | Sep 30, 2018 | -$17.26M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.94M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.18M | – |
See a number that looks wrong?